David Scott Moore

DIRECTOR · CORVUS PHARMACEUTICALS, INC. · CIK 0002088466

FILING MIX · LIFETIME100%/0%

BUYS

SELLS

TOTAL VALUE

$250.2K

COMPANIES

ACTIVE SINCE

Oct 2025

HOLDINGS NOW

21,700

AVG SELL PX

—

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

No backtest data available for David Scott Moore. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.

Holdings over time

CRVS · 21,700 shares · as of Jun 11, 2026

Trading cadence · quarterly flow

BUY ● SELL ●

2025

2026

FLOW · 3 buys / 0 sellsCOVERAGE · 3 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
CRVS CORVUS PHARMACEUTICALS, INC.	PURCHASE	21,700	$11.53	$250.2K	21,700	Jun 11, 2026	Jun 15, 2026 ↗	View →
CRVS CORVUS PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	15,000	—	—	15,000	Jun 11, 2026	Jun 15, 2026 ↗	View →
CRVS CORVUS PHARMACEUTICALS, INC.	PURCHASEGRANT Stock grant	30,000	—	—	30,000	Oct 2, 2025	Oct 6, 2025 ↗	View →

Other insiders · CRVS

Loading peer insiders…

About this filer

CIK 0002088466

ROLE

Director

PRIMARY

CRVS

COMPANIES

ACTIVE SINCE

Oct 2025

MARKETPEEL · /INSIDER/0002088466DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

The morning brief, before the bell.